Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: A randomized, double-blind, placebo-controlled study

BACKGROUND: Although several clinical trials have evaluated the impact of n-3 polyunsaturated fatty acid (PUFA) on patients with attention-deficit hyperactivity disorder (ADHD), changes in plasma PUFA composition were not always assessed following n-3 supplementation. Furthermore, no reports are ava...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Bélanger, Stacey Ageranioti, Vanasse, Michel, Spahis, Schohraya, Sylvestre, Marie-Pierre, Lippé, Sarah, l’Heureux, François, Ghadirian, Parviz, Vanasse, Catherine-Marie, Levy, Emile
Format: Artigo
Jezik:Inglês
Izdano: Pulsus Group Inc 2009
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2661342/
https://ncbi.nlm.nih.gov/pubmed/19436468
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items